Jennison Associates LLC Trims Holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Jennison Associates LLC lessened its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 5.7% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 1,082,810 shares of the company's stock after selling 65,945 shares during the period. Jennison Associates LLC owned approximately 1.17% of Acadia Healthcare worth $85,780,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the stock. Quent Capital LLC grew its position in Acadia Healthcare by 8.1% during the 1st quarter. Quent Capital LLC now owns 3,784 shares of the company's stock worth $300,000 after purchasing an additional 284 shares during the last quarter. BNP Paribas Financial Markets grew its position in Acadia Healthcare by 77.1% during the 1st quarter. BNP Paribas Financial Markets now owns 21,453 shares of the company's stock worth $1,700,000 after purchasing an additional 9,342 shares during the last quarter. Peterson Wealth Services purchased a new stake in shares of Acadia Healthcare in the 1st quarter valued at $2,739,000. Retirement Systems of Alabama boosted its holdings in shares of Acadia Healthcare by 0.3% in the 1st quarter. Retirement Systems of Alabama now owns 115,799 shares of the company's stock valued at $9,174,000 after acquiring an additional 303 shares during the last quarter. Finally, OFI Invest Asset Management boosted its holdings in shares of Acadia Healthcare by 2.5% in the 1st quarter. OFI Invest Asset Management now owns 164,427 shares of the company's stock valued at $12,061,000 after acquiring an additional 4,013 shares during the last quarter.

Acadia Healthcare Stock Down 0.3 %

NASDAQ:ACHC traded down $0.21 during mid-day trading on Tuesday, hitting $65.43. The stock had a trading volume of 668,597 shares, compared to its average volume of 717,009. The stock has a 50-day simple moving average of $67.56 and a two-hundred day simple moving average of $75.35. The company has a market capitalization of $6.07 billion, a PE ratio of -467.32, a PEG ratio of 1.98 and a beta of 1.31. Acadia Healthcare Company, Inc. has a twelve month low of $62.04 and a twelve month high of $87.77. The company has a current ratio of 1.27, a quick ratio of 1.27 and a debt-to-equity ratio of 0.63.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its earnings results on Thursday, May 2nd. The company reported $0.84 earnings per share for the quarter, beating the consensus estimate of $0.80 by $0.04. The firm had revenue of $768.10 million for the quarter, compared to analysts' expectations of $779.20 million. Acadia Healthcare had a negative net margin of 0.38% and a positive return on equity of 11.49%. The firm's revenue was up 9.1% compared to the same quarter last year. During the same quarter last year, the company earned $0.75 earnings per share. On average, equities research analysts anticipate that Acadia Healthcare Company, Inc. will post 3.52 EPS for the current year.

Analysts Set New Price Targets

Several analysts have recently commented on the stock. Royal Bank of Canada reaffirmed an "outperform" rating and issued a $94.00 price objective on shares of Acadia Healthcare in a report on Wednesday, May 22nd. Cantor Fitzgerald reissued a "neutral" rating and set a $90.00 price target on shares of Acadia Healthcare in a report on Tuesday. Mizuho lowered their price target on shares of Acadia Healthcare from $84.00 to $70.00 and set a "neutral" rating on the stock in a report on Friday, May 3rd. Barclays lowered their price target on shares of Acadia Healthcare from $91.00 to $89.00 and set an "overweight" rating on the stock in a report on Wednesday, May 15th. Finally, StockNews.com downgraded shares of Acadia Healthcare from a "hold" rating to a "sell" rating in a report on Tuesday, May 21st. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and six have given a buy rating to the company. According to MarketBeat, Acadia Healthcare has an average rating of "Moderate Buy" and a consensus target price of $87.56.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.